INTRODUCTION {#S1}
============

Transcription by RNA polymerase II (RNAPII) in metazoans is governed at multiple stages, allowing for the precise execution of gene expression programs critical to cellular development and homeostasis. During formation of the preinitiation complex, general transcription factors coalesce around the promoter and orient RNAPII at transcription start sites (TSSs). The XPB helicase, a component of TFIIH, unwinds the local chromatin and enables RNAPII to initiate transcription from single-stranded template DNA ([@R42]). RNAPII undergoes promoter escape, where it breaks contacts with promoter elements and preinitiation machinery to begin elongation. A critical regulatory step occurs after RNAPII transcribes 20--120 nt from the TSS, where it transiently stalls in the vicinity of the +1 nucleosome ([@R6]). This phenomenon, known as RNAPII promoter-proximal pausing, was initially described at heat-shock-inducible genes in *Drosophila* and has since been the subject of intense investigation in the genome-wide era ([@R41]). Surprisingly, these studies revealed that most RNAPII-transcribed genes display greatest RNAPII occupancy in promoter regions, establishing that RNAPII proximal pausing is ubiquitous in the genome ([@R32]; [@R39]; [@R56]). The involvement of these genes in development, stimulus responsiveness, and cellular reproduction suggests that multicellular organisms evolved RNAPII proximal pausing as an additional regulatory layer in the expression of critical genes ([@R56]).

Numerous factors contribute to the establishment and maintenance of paused RNAPII, including sequence-specific and general transcription factors, negative elongation factor (NELF), DRB-sensitivity inducible factor (DSIF), polymerase-associated factor 1 (PAF1), and Gdown1 ([@R6]). In addition, DNA/RNA hybrids and the +1 nucleosome have also been shown to promote RNAPII pausing by imposing an energetic barrier that obstructs RNAPII entry into gene bodies ([@R3]; [@R11]; [@R50]; [@R51]; [@R52]). Release of RNAPII and its nascent RNA into productive elongation relies on the kinase activity of P-TEFb, which phosphorylates NELF, SPT5 (a subunit of DSIF), and serine-2 on the RNAPII C-terminal domain ([@R37]).

Our previous studies demonstrate that the Integrator complex mediates RNAPII pause-release through its recruitment of P-TEFb and AFF4, two components of the super elongation complex (SEC) ([@R15]). Other groups have shown that Integrator also associates with NELF and DSIF, suggesting that Integrator may also functionally coordinate with factors that promote pausing ([@R46]; [@R54]). The engagement of Integrator and the SEC is critical for activating the mitogen-activated protein kinase (MAPK) gene expression program, though less is known about the mechanisms by which Integrator regulates transcription and RNAPII pause-release genome-wide ([@R15]; [@R55]).

Integrator is a metazoan-restricted multisubunit protein complex that is intimately associated with the phosphorylated form of RNAPII ([@R2]; [@R10]; [@R12]; [@R44]). Integrator harbors a RNA endonuclease subunit, Integrator subunit 11 (INTS11), and our initial characterization of the complex revealed its role in the 3′ end processing of small nuclear RNAs involved in spliceosome formation ([@R2]). It is now understood that the enzymatic activity of Integrator requires functional association of the INTS11/INTS9 heterodimer with INTS4 to collectively form the catalytically active cleavage module ([@R1]; [@R53]). In an effort to identify novel RNA substrates of Integrator, we recently found that Integrator is critical for the biogenesis and 3′ end processing of enhancer RNAs (eRNAs), thus expanding the scope of Integrator function and enhancer regulation ([@R15]; [@R23]).

Promoters and enhancers share conserved structural and functional features including DNase I hypersensitivity and nucleosome positioning, transcription factor occupancy, histone acetylation, and bidirectional transcription ([@R19]). We sought to understand how Integrator regulates transcription at these loci, with a specific interest in the role of its catalytic activity. We find that Integrator regulates RNAPII recruitment genome-wide, independent of its enzymatic activity. At numerous human genes, INTS11 mediates RNAPII pause-release through endonucleolytic cleavage of nascent transcripts, allowing for the reinitiation of an elongation-competent RNAPII complex. At enhancers, INTS11 catalysis is needed strictly for the termination of eRNA transcription. Such mechanistic distinctions are reflected in the increased occupancy of pause factors (NELF and SPT5) following Integrator depletion at promoters. Our results highlight fundamental differences in the regulation of transcription at human promoters and enhancers. This work places Integrator as a critical determinant in the recruitment and dynamic turnover of RNAPII, where it initiates and terminates numerous rounds of transcription to promote productive elongation through the +1 nucleosome.

RESULTS {#S2}
=======

Transcriptional Circuitry of the Human Integrator Core Catalytic Module {#S3}
-----------------------------------------------------------------------

To gain insight into the transcriptional targets regulated by INTS11, INTS9, and INTS4, the core subunits of the Integrator catalytic module, we generated HeLa cells with stable doxycycline-inducible (Dox) short hairpin RNA against each subunit in addition to a short hairpin RNA (shRNA) against green fluorescent protein (control shRNA) ([Figure S1A](#SD1){ref-type="supplementary-material"}). Interestingly, while depletion of INTS4 did not affect the stability of INTS11 or INTS9, reduction of either INTS11 or INTS9 leads to the loss of both proteins, reflecting their association as obligate partners ([Figure S1A](#SD1){ref-type="supplementary-material"}). We performed total RNA sequencing (RNA-seq) to assess their genome-wide effect on 24,832 expressed genes in HeLa cells ([Table S1](#SD2){ref-type="supplementary-material"}). All genome-wide results presented are a merge of at least two independent biological replicates. Knockdown of INTS11, INTS9, or INTS4 resulted in the differential expression of 5,347, 7,423, and 5,692 genes respectively, and nearly half in each condition were down- or upregulated ([Figures 1A](#F1){ref-type="fig"}-[1C](#F1){ref-type="fig"}; [Table S2](#SD3){ref-type="supplementary-material"}). Moreover, we found 1,898 core genes whose expression was collectively regulated by the three subunits where \~950 genes were commonly down- or upregulated ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}; [Table S2](#SD3){ref-type="supplementary-material"}). Transcriptional repressors and heterochromatin regulators were the predominant Gene Ontology categories of downregulated genes, pointing to a role of the catalytic module in regulating genes involved in transcriptional repression. Upregulated pathways included those related to epidermal growth factor signaling, consistent with reports in *Drosophila* ([Table S3](#SD4){ref-type="supplementary-material"}) ([@R13]).

Nascent Transcript Sequencing Reveals a Predominant Role for Integrator in Mediating the Transition to Productive Elongation {#S4}
----------------------------------------------------------------------------------------------------------------------------

To mechanistically dissect the direct functions of Integrator in transcription, we first performed chromatin immunoprecipitation sequencing (ChIP-seq) of INTS11 and RNAPII and found strong correlation in their genome-wide occupancy, in agreement with biochemical evidence ([Figure 2A](#F2){ref-type="fig"}) ([@R2]). Next, we depleted INTS11 and performed precision run-on and sequencing (PRO-seq), which provides single-nucleotide resolution of the leading edge of RNAPII engaged in transcription ([Figure S2A](#SD1){ref-type="supplementary-material"}) ([@R22]). We also performed cap analysis of gene expression (CAGE) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) to determine the positions of transcriptional initiation and the +1 nucleosome, respectively. Multiple bioinformatic filters were used to assess transcriptionally engaged RNAPII, including detectable signal from RNA-seq, PRO-seq, and CAGE, and a positioned +1 nucleosome within 500 nt from the CAGE signal ([Figure S2B](#SD1){ref-type="supplementary-material"}). These cutoffs yielded 8,000 genes ([Figure S2B](#SD1){ref-type="supplementary-material"}). We used PRO-seq to calculate the RNAPII traveling ratio (TR) as the density of RNAPII in the promoter region (defined here as −50 nt from CAGE to +300 nt) over the region corresponding to the gene body (+301 nt from CAGE to TES), which allows for genome-wide assessment of RNAPII behavior ([@R39]). We detected an increase in the TR after depletion of INTS11, suggesting that Integrator is required for RNAPII pause-release ([Figures S2C](#SD1){ref-type="supplementary-material"} and [S2D](#SD1){ref-type="supplementary-material"}). However, an increased TR does not provide sufficient mechanistic evidence that Integrator is required to license transcriptional elongation. To more thoroughly examine transcriptional dynamics, we separated the PRO-seq signal into promoter and gene body regions (defined above), as these loci correspond to transcriptional initiation and elongation, respectively. We also centered the PRO-seq promoter profiles on the +1 nucleosome dyad to assess the response of RNAPII as it encounters the +1 nucleosome barrier ([Figures S2E](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}). Depletion of INTS11 led to an increase and shift of RNAPII toward 3′ end of the promoter region ([Figure S2F](#SD1){ref-type="supplementary-material"}). Moreover, we observed reduced read density through the gene body, reflecting impaired elongation ([Figure S2F](#SD1){ref-type="supplementary-material"}).

The Traveling Matrix Defines a Transcriptional Initiation to Elongation Continuum {#S5}
---------------------------------------------------------------------------------

Measurements of the TR pose a major limitation in that the same value can result from reduced signal in the gene body or increased reads in the promoter, obscuring transcriptional dynamics ([Figure 2B](#F2){ref-type="fig"}, compare conditions B and C). Assessment of the TR and RNAPII average profiles provide a representative insight into global gene expression changes, though we strived to understand the response of individual genes to INTS11 depletion. Therefore, we devised a two-dimensional Gaussian distribution of RNAPII, which we termed the traveling matrix (TM), to simultaneously dissect the alterations at promoters and gene bodies of INTS11-responsive genes ([Figure 2B](#F2){ref-type="fig"}). The TM resolves changes in the promoter and gene body regions of individual genes, which are then represented as a two-dimensional topographic map. The color intensity in the TM displays the concentration of genes at a particular position. Induction of control shRNA minimally changed its TM, as most genes were centered close to the origin of the two-dimensional graph ([Figures 2C](#F2){ref-type="fig"} and [S2G](#SD1){ref-type="supplementary-material"}, which depict individual genes). In contrast, depletion of INTS11 induced an extensive transcriptional effect, as the TM coordinates of numerous genes were altered ([Figures 2D](#F2){ref-type="fig"} and [S2H](#SD1){ref-type="supplementary-material"}). Consistent with the average profiles, the genes in the INTS11 TM showed reduced gene body read density ([Figure 2D](#F2){ref-type="fig"}, note the downward shift of the matrix).

We set the control TM as the baseline expected null dispersion and excluded these genes from the INTS11 TM to identify genes that significantly (false discovery rate \[FDR\] \< 0.05) differ from the expected control dispersion. We named this matrix the differential TM ([Figures 2E](#F2){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}). We then divided the differential TM into four gene class quadrants (class I--IV), representing differentially expressed genes with coincident changes in promoter and gene body signal ([Table S4](#SD5){ref-type="supplementary-material"}). While INTS11 depletion altered many gene coordinates in the differential TM (compare [Figures 2C](#F2){ref-type="fig"} and [2D](#F2){ref-type="fig"}; also see [Figures S2G](#SD1){ref-type="supplementary-material"} and [S2H](#SD1){ref-type="supplementary-material"}), the majority of INTS11-responsive genes accumulated in class III and IV quadrants, signifying a loss of transcriptional elongation ([Figures 2E](#F2){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}). Moreover, the pronounced enrichment of genes in class IV, where augmented promoter signal is coupled with reduced gene body reads, implicates a requirement for INTS11 in mediating RNAPII pause-release and productive elongation at these loci. Consistent with their responsiveness to INTS11 depletion, class IV genes show the highest levels of INTS11 and RNAPII occupancy at their promoters ([Figures 2F](#F2){ref-type="fig"} and [2G](#F2){ref-type="fig"}). [Figures 2H](#F2){ref-type="fig"} and [2I](#F2){ref-type="fig"} depict single-nucleotide PRO-seq tracks for two representative class IV genes following control or INTS11 shRNA induction.

The Requirement of Integrator at Human Genes with a Highly Positioned +1 Nucleosome {#S6}
-----------------------------------------------------------------------------------

To understand how INTS11 regulates transcription of the four gene classes determined by the differential TM, we displayed the promoter profile of engaged RNAPII centered on the +1 nucleosome and depicted the gene body profile from its first 25% to the TES ([Figures 3A](#F3){ref-type="fig"}-[3D](#F3){ref-type="fig"}). Class III and IV genes represent the majority of INTS11-responsive genes (n = 2,104 or 67%), which showed decreased read density in their gene bodies upon depletion of INTS11 ([Figure 3D](#F3){ref-type="fig"}). As seen in the differential TM, class IV genes exhibited a substantial increase in paused RNAPII in proximity of +1 nucleosome, and the peak of RNAPII was also shifted toward the center of the dyad ([Figure 3D](#F3){ref-type="fig"}). This behavior was also noted in class II genes ([Figure 3B](#F3){ref-type="fig"}). In contrast, class III and I genes showed decreased read density close to +1 nucleosome without a change in the position of RNAPII ([Figures 3B](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}). Analysis of the TR illuminated elongation defects in class II, III, and IV genes, while this impairment was most pronounced at class IV genes ([Figures S3A](#SD1){ref-type="supplementary-material"}-[S3D](#SD1){ref-type="supplementary-material"}). Importantly, these alterations in nascent transcription were largely recapitulated in steady-state gene expression ([Figure S3E](#SD1){ref-type="supplementary-material"}). The PRO-seq results were then validated using ChIP-seq of total RNAPII, which showed comparable profiles of RNAPII at promoters and gene bodies of the four classes of genes ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Interestingly, while depletion of INTS11 did not impact the position of the +1 nucleosome in the four classes of genes, the two gene classes (II and IV) that featured increased RNAPII pausing showed highest ATAC-seq read density of the +1 nucleosome ([Figures 3G](#F3){ref-type="fig"}-[3J](#F3){ref-type="fig"}). The enhanced positioning of the +1 nucleosome at class IV genes was coupled with high-occupancy histone H3 lysine 4 trimethylation (H3K4me3) and histone H3 lysine 36 trimethylation (H3K36me3) and low enrichment of histone H3 lysine 4 monomethylation (H3K4me1) ([Figures S3F](#SD1){ref-type="supplementary-material"}-[S3H](#SD1){ref-type="supplementary-material"}). Notably, class I genes displayed the lowest levels of H3K4me3 and H3K36me3 compared to the other classes, consistent with their low expression ([Figures S3F](#SD1){ref-type="supplementary-material"}-[S3I](#SD1){ref-type="supplementary-material"}). Taken together, we find that at genes with a highly positioned +1 nucleosome decorated in H3K4me3, INTS11 depletion elicits a substantial increase in RNAPII pausing in conjunction with reduced elongation, as exemplified by class IV genes in the differential TM.

Integrator Catalytic Activity Relieves RNAPII Pausing and Contributes to Transcriptional Elongation {#S7}
---------------------------------------------------------------------------------------------------

Few studies have examined the direct contribution of INTS11 catalytic activity to gene expression and Integrator function. Accordingly, we depleted INTS11 and performed a rescue experiment by ectopically expressing wild-type INTS11 (WT-INTS11) or its catalytic mutant INTS11 (E203Q-INTS11) from a sequence refractory to the shRNA ([Figure S4A](#SD1){ref-type="supplementary-material"}). Exogenous expression of WT-INTS11 rescued the changes incurred by INTS11 depletion at all genes and the four gene classes, as seen by the average profiles and the TR ([Figures 4A](#F4){ref-type="fig"}-[4F](#F4){ref-type="fig"} and [S4B](#SD1){ref-type="supplementary-material"}-[S4I](#SD1){ref-type="supplementary-material"}). In contrast, rescue with INTS11-E203Q produced a similar average profile and TR to that of INTS11 depletion at all 8,000 genes, indicating increased RNAPII pausing and decreased elongation ([Figures S2C](#SD1){ref-type="supplementary-material"}-[S2F](#SD1){ref-type="supplementary-material"} and [S4B](#SD1){ref-type="supplementary-material"}-[S4E](#SD1){ref-type="supplementary-material"}). Examination of the average profiles at the four gene classes revealed that at class II and IV genes, INTS11 catalysis is required for the release of paused RNAPII into productive elongation ([Figures 4B](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}; see examples in [Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}). Class III and IV genes highlighted the requirement of INTS11 catalysis for transcriptional elongation, as the reduction in gene body read density was not restored by E203Q-INTS11 expression ([Figures 4D](#F4){ref-type="fig"}, [S4H](#SD1){ref-type="supplementary-material"}, and [S4I](#SD1){ref-type="supplementary-material"}). Strikingly, the impaired recruitment of RNAPII to class I and III genes was rescued by E203Q-INTS11 expression, thus delineating a catalytic-independent role of Integrator in the recruitment of RNAPII to these genes ([Figures 4B](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}). At class III genes, while E203Q-INTS11 expression corrected RNAPII recruitment defects, the reduction in gene body read density persisted, affirming the essentiality of INTS11 catalysis in the transition of RNAPII to productive elongation ([Figure 4D](#F4){ref-type="fig"}). Notably, the read density in the bodies of the class I and II genes increased to a lesser extent compared to that of INTS11 depletion ([Figure 3B](#F3){ref-type="fig"} versus [Figure 4B](#F4){ref-type="fig"}). In summary, we find that INTS11 catalytic activity is needed to release RNAPII pausing in the proximity of the +1 nucleosome and promote transcriptional elongation at numerous human genes ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}).

INTS11 Induces Premature Termination of Stalled RNAPII Transcripts at Human Promoters {#S8}
-------------------------------------------------------------------------------------

Our experiments demonstrate that in the proximity of +1 nucleosome, the catalytic activity of INTS11 is required for the release of paused RNAPII into productive elongation. We surmised that nascent transcripts protruding from the active site of RNAPII undergo endonucleolytic cleavage by INTS11 and prematurely terminate, allowing for new rounds of initiation ([@R45]). To address this hypothesis, we performed small RNA (smRNA) sequencing. We detected an enrichment of smRNA in the 5′ end of all genes and subsequently analyzed the reads that mapped to the first 150 nt from the TSS ([Figure 5A](#F5){ref-type="fig"}). The presence of smRNA was observed at all classes of genes, indicating that the generation of RNAPII-associated smRNA is pervasive throughout the genome ([Figures 5B](#F5){ref-type="fig"}, [5C](#F5){ref-type="fig"}, [S5A](#SD1){ref-type="supplementary-material"}, and [S5B](#SD1){ref-type="supplementary-material"}). This is in line with previous studies that showed the production of smRNA was not exclusive to genes with paused RNAPII, despite their enrichment at paused sites ([@R33]; [@R48]). We found that the amount of smRNA at class II and IV genes was unchanged in all conditions, while at class I and III genes, the level of smRNA in INTS11-depleted cells was reduced due to impaired RNAPII recruitment ([Figures 5B](#F5){ref-type="fig"}, [5C](#F5){ref-type="fig"}, [S5A](#SD1){ref-type="supplementary-material"}, and [S5B](#SD1){ref-type="supplementary-material"}; see [Figure 3B](#F3){ref-type="fig"}).

We previously established that depletion of INTS11 or overexpression of E203Q-INTS11 compromises UsnRNA (uridylaterich small nuclear RNA) termination, resulting in RNAPII read-through and transcript lengthening ([@R2]). Interestingly, analysis of smRNA read length illuminated the extension of transcripts in E203Q-INTS11 cells at baseline, suggesting that E203Q-INTS11 exerted a dominant-negative effect on RNA processing prior to the depletion of endogenous INTS11 ([Figure 5D](#F5){ref-type="fig"}). Evidence from the aforementioned studies implicate that defects in premature termination would be accentuated at class II and IV genes, as they display pronounced stalling of RNAPII in the absence of INTS11 or its catalytic activity ([@R33]; [@R48]). Indeed, the mean read length of smRNA at these classes increased following depletion of INTS11, consistent with the augmented pausing of RNAPII and its 3′-shift toward the center of the +1 nucleosome dyad ([Figures 5E](#F5){ref-type="fig"} and [S5C](#SD1){ref-type="supplementary-material"}; see [Figures 3D](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). At class III genes, knockdown of INTS11 generated shorter smRNA extensions compared to that of class II and IV genes, owing to the reduction in RNAPII recruitment ([Figure 5F](#F5){ref-type="fig"}; see [Figures 3D](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Importantly, ectopic expression of WT-INTS11 rescued the lengthening of smRNA transcripts at all classes, while expression of E203Q-INTS11 failed to do so ([Figures 5G](#F5){ref-type="fig"}, [5H](#F5){ref-type="fig"}, [S5E](#SD1){ref-type="supplementary-material"}, and [S5F](#SD1){ref-type="supplementary-material"}). We noted that the magnitude of smRNA lengthening was subdued by the dominant-negative activity of E203Q-INTS11; however, the importance of INTS11 catalytic activity in smRNA processing was underscored at all gene classes ([Figures 5E](#F5){ref-type="fig"}-[5H](#F5){ref-type="fig"} and [S5C](#SD1){ref-type="supplementary-material"}-[S5F](#SD1){ref-type="supplementary-material"}).

Further dissection of smRNA by the read length distribution revealed two populations of transcripts that originate from TSSs with average sizes of 21 and 41 nt, respectively ([Figures 5I](#F5){ref-type="fig"}-[5L](#F5){ref-type="fig"} and [S5G](#SD1){ref-type="supplementary-material"}-[S5J](#SD1){ref-type="supplementary-material"}). After INTS11 knockdown, we observed an accumulation and extension of the 41-nt smRNA population concomitant with a depletion of the 21-nt smRNA population ([Figures 5J](#F5){ref-type="fig"} and [S5H](#SD1){ref-type="supplementary-material"}). This processing defect was rescued by WT-INTS11 yet persisted in cells expressing E203Q-INTS11, indicating that the population of 21-nt transcripts correspond to the cleavage product of INTS11 catalysis ([Figures 5K](#F5){ref-type="fig"}, [5L](#F5){ref-type="fig"}, and [S5I](#SD1){ref-type="supplementary-material"}-[S5J](#SD1){ref-type="supplementary-material"}). Taken together, these data demonstrate a role for Integrator and the catalytic activity of INTS11 in the termination of RNAPII-associated nascent transcripts at genes with high levels of paused RNAPII ([Figures 5M](#F5){ref-type="fig"} and [5N](#F5){ref-type="fig"}).

Integrator Terminates Transcription at Human Enhancers {#S9}
------------------------------------------------------

We asked whether our findings at promoters were generalizable to enhancer regions given the known requirement for Integrator in the biogenesis and 3′ end processing of eRNA. We evaluated RNAPII profiles at 2,293 enhancers by finding common intergenic H3K27ac and H3K4me1 peaks and excluded regions that overlap within 2 kb of an annotated TSS. We then centered the reads of the bidirectional eRNA transcripts on the maximum PRO-seq signal ([Figures 6A](#F6){ref-type="fig"}-[6D](#F6){ref-type="fig"} and [S6A](#SD1){ref-type="supplementary-material"}). Consistent with previous observations at epidermal-growth-factor-responsive enhancers, depletion of INTS11 produced a global defect in eRNA termination, as demonstrated by the extension of RNAPII reads and accumulation of transcripts beyond their canonical 3′ end ([Figures 6A](#F6){ref-type="fig"}-[6D](#F6){ref-type="fig"} and [S6B](#SD1){ref-type="supplementary-material"}). This was particularly evident in cells expressing E203Q-INTS11 following the knockdown of INTS11 (compare [Figures 6C](#F6){ref-type="fig"} and [6D](#F6){ref-type="fig"}). We then centered PRO-seq reads on the +1 nucleosome as promoters and enhancers share remarkably conserved transcriptional architecture, including well-positioned +1 and −1 nucleosomes ([@R8]). Knockdown of INTS11 also decreased recruitment of RNAPII to enhancers, similar to that observed at class I and III promoters ([Figures 6E](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, and [3A](#F3){ref-type="fig"}-[3F](#F3){ref-type="fig"}). Strikingly, expression of both WT-INTS11 and E203Q-INTS11 restored defects in RNAPII occupancy incurred by the loss of INTS11, further attesting to the catalytic-independent role of Integrator in the recruitment of RNAPII ([Figures 6G](#F6){ref-type="fig"} and [6H](#F6){ref-type="fig"}). We next determined the TR and TM at enhancers. In agreement with the PRO-seq average profiles, the TR at enhancers displayed augmented transcriptional elongation resulting from decreased RNAPII density at the TSS and an accumulation of reads within enhancer bodies ([Figures S6C](#SD1){ref-type="supplementary-material"}-[S6F](#SD1){ref-type="supplementary-material"}). The TM at enhancers was entirely different from that of promoters ([Figures 6I](#F6){ref-type="fig"}, [6J](#F6){ref-type="fig"}, [S6G](#SD1){ref-type="supplementary-material"}, [S6H](#SD1){ref-type="supplementary-material"}, [2C](#F2){ref-type="fig"}, [2D](#F2){ref-type="fig"}, [S2G](#SD1){ref-type="supplementary-material"}, and [S2H](#SD1){ref-type="supplementary-material"}). While INTS11 depletion lead to reduced reads in the bodies of most genes as shown in [Figure 2D](#F2){ref-type="fig"}, enhancers featured enhanced reads in their bodies beyond the +1 nucleosome, reflecting impaired termination ([Figure 6B](#F6){ref-type="fig"} and [6J](#F6){ref-type="fig"}). The differential TM at enhancers also depicted a pattern considerably different from the differential TM at promoters (compare [Figures 6K](#F6){ref-type="fig"}, [S6I](#SD1){ref-type="supplementary-material"}, [2E](#F2){ref-type="fig"}, and [S2I](#SD1){ref-type="supplementary-material"}). Notably, only a few enhancers showed increased RNAPII-stalling after INTS11 knockdown, suggesting that Integrator plays little role in RNAPII pause-release at enhancers. These data indicate that Integrator is required for the global recruitment of RNAPII to enhancers and promoters independent of its catalytic activity. At promoters, INTS11 catalysis facilitates transcriptional elongation through the premature termination of nascent mRNA adjacent to the +1 nucleosome, while at enhancers, the endonuclease activity of INTS11 is needed strictly for the termination of eRNA transcripts beyond the +1 nucleosome.

Factors Associated with RNAPII Pausing Display a Differential Behavior at Promoters and Enhancers {#S10}
-------------------------------------------------------------------------------------------------

Finally, we analyzed factors associated with RNAPII pause-release at promoters and enhancers following depletion of INTS11. In agreement with the increased RNAPII pausing observed at promoters of class II and IV genes, knockdown of INTS11 increased occupancy of the NELF subunit NELF-E and the DSIF subunit SPT5 ([Figures 7A](#F7){ref-type="fig"}, [7B](#F7){ref-type="fig"}, [S7A](#SD1){ref-type="supplementary-material"}, and [S7B](#SD1){ref-type="supplementary-material"}). At enhancers, NELF-E levels were reduced, in line with decreased RNAPII recruitment ([Figure 7C](#F7){ref-type="fig"}). Moreover, while SPT5 levels were unchanged around eRNA start sites, there was increased occupancy in enhancer bodies ([Figure 7D](#F7){ref-type="fig"}). We evaluated levels of tyrosine-1-phosphorylated RNAPII (RNAPII-Y1), which was shown to be required for transcriptional termination and functionally associated with Integrator by mass spectroscopy ([@R30]; [@R44]). After INTS11 depletion, elevated levels of RNAPII-Y1 were found at enhancers and at promoters of class II and IV genes, consistent with the pronounced defects in RNA processing at these sites ([Figures 7E](#F7){ref-type="fig"}, [7F](#F7){ref-type="fig"}, [S7C](#SD1){ref-type="supplementary-material"}, [5A](#F5){ref-type="fig"}, and [S5A](#SD1){ref-type="supplementary-material"}). In contrast, promoters of class I and III genes were reduced in RNAPII-Y1 occupancy due to impaired recruitment of RNAPII ([Figures 7E](#F7){ref-type="fig"} and [S7C](#SD1){ref-type="supplementary-material"}). This was further confirmed through analysis of serine-5-phosphorylated RNAPII (RNAPII-S5), which was similarly diminished at these classes ([Figures S7D](#SD1){ref-type="supplementary-material"} and [S7E](#SD1){ref-type="supplementary-material"}). Moreover, occupancy of serine-2-phosphorylated RNAPII (RNAPII-S2) closely mirrored the PRO-seq gene body profiles at the four classes of genes ([Figures S7F](#SD1){ref-type="supplementary-material"} and [S7G](#SD1){ref-type="supplementary-material"}). To ascertain whether these results could be visualized in cells, we performed STORM (stochastic optical reconstruction microscopy) imaging of INTS1 and RNAPII-Y1, which revealed highly colocalized signals in large clusters throughout the nucleus ([Figures 7G](#F7){ref-type="fig"} and [S7D](#SD1){ref-type="supplementary-material"}). Strikingly, depletion of INTS11 significantly increased the density of these clusters ([Figures 7H](#F7){ref-type="fig"} and [S7E](#SD1){ref-type="supplementary-material"}), in agreement with the elevated ChIP-seq profile of RNAPII-Y1 at paused genes and enhancers. In summary, these findings link the catalytic activity of Integrator to premature termination and RNAPII pause-release at promoters and transcriptional termination at enhancers.

DISCUSSION {#S11}
==========

Here, we show that depletion of Integrator subunits that compose the catalytic module (INTS11, INTS9, and INTS4) leads to alterations in steady-state gene expression, consistent with previous reports ([@R15]; [@R23]; [@R46]; [@R54]; [@R55]). While recent studies indicate that *Drosophila* Integrator primarily attenuates gene expression, our data demonstrate that Integrator plays a role in the repression and activation of human genes ([@R49]; [@R13]). For example, we found more than half of 7,425 differentially expressed genes were downregulated after knockdown of human INTS9, while depletion of *Drosophila* INTS9 reduced expression of \<18% of genes ([@R49]; [@R13]). Interestingly, upregulated Gene Ontology pathways were the most conserved between these species, suggesting that throughout evolution the scope of Integrator expanded from a set of repressed target genes to include those that require its function for activation. We previously showed that Integrator is stably associated with the C-terminal domain of RNAPII, and ChIP-seq analysis of INTS11 and RNAPII showed highly correlated genomic occupancy at 8,000 genes (r = 0.79). In *Drosophila*, only a 39% correlation was found between INTS1 and PRO-seq signals at 9,499 genes, suggesting differences in Integrator occupancy, RNAPII association, and regulatory function in lower metazoans.

To address the direct contribution of Integrator to transcription at promoters and enhancers in human cells, we depleted INTS11 and performed PRO-seq. We utilized a two-dimensional TM to project the positional changes in RNAPII at promoters and gene bodies incurred by the loss of INTS11. Strikingly, more than two-thirds of differentially regulated genes exhibited a loss of RNAPII signal in gene bodies, indicating that Integrator promotes transcriptional elongation in human cells. Half of these genes displayed deficient RNAPII recruitment, whereas the other half showed increased RNAPII pausing. This reduction in elongating RNAPII was evident in the steady-state levels of RNA, which were largely diminished in these classes. Critically, ectopic expression of E203Q-INTS11 restored recruitment of RNAPII, while defects in pause-release persisted. Thus, utilization of catalytic-dead INTS11 in conjunction with the TM illuminated the mechanistically distinct roles of Integrator in the recruitment of RNAPII and its catalytic activity in the transition of RNAPII to productive elongation.

Class IV genes determined by the TM featured Integrator-dependent RNAPII pausing, a strongly positioned +1 nucleosome decorated in H3K4me3, gene bodies enriched in H3K36me3, and were most occupied by INTS11 and RNAPII compared to the other classes. These results contrast a recent report in *Drosophila* that shows a repressive function of Integrator at lowly expressed genes and its anticorrelation with H3K4me3 and H3K36me3 ([@R13]). Furthermore, we found an inverse correlation of Integrator occupancy and H3K4me1, also in opposition to this work. Interestingly, high levels of H3K4me1 and low levels of H3K4me3 and H3K36me3 were characteristic of class I genes, which featured an epigenetic landscape most closely attributed to enhancer elements. Notably, this class comprised the fewest Integrator-responsive genes in our study (327 of 3,125 genes), which is consistent with a small set of lowly expressed genes in *Drosophila* that display de-repression upon Integrator depletion ([@R13]). These data suggest that throughout evolution, Integrator acquired a predominant function in the transcriptional activation of genes that require INTS11 catalysis for pause-release and elongation.

We found that loss of INTS11 or ectopic expression of E203Q-INTS11 resulted in not only an accumulation of paused RNAPII but also a 3′-shift of RNAPII peak toward the center of the +1 nucleosome dyad. Remarkably, smRNA transcripts concomitantly lengthened over this region, demonstrating the requirement of INTS11 catalysis for their termination. Importantly, the levels of smRNA were unchanged at all gene classes in cells expressing E203Q-INTS11, which argues against a role for Integrator in regulating smRNA stability. Closer examination of smRNA revealed two populations that emanate from TSSs: a 21-nt cleavage product that reduced upon loss of INTS11 or its catalytic activity and another 41-nt population that extended as a consequence of defective processing. While a recent report in *Drosophila* attributes numerous promoter-associated transcripts \>80 nt as Integrator dependent, the smRNA in the present study is consistent with the length reported in previous literature and demonstrated conditional size changes that mechanistically reflect defective endonucleolytic processing ([@R18]; [@R33]; [@R48]; [@R49]). These results indicate that INTS11 terminates nascent transcripts to rapidly evict paused RNAPII from the chromatin. This allows for the subsequent recruitment of an elongation-competent RNAPII complex to traverse the +1 nucleosome and elongate into the body of genes ([@R14]; [@R21]; [@R45]; [@R47]).

Genome-wide studies have found numerous commonalities between two classes of transcriptional regulatory elements, promoters, and enhancers ([@R19]). Indeed, examination of these distinct loci found architectural commonalities, including DNA sequence, transcription factor occupancy, and nucleosome deposition. We wondered whether the functions of Integrator are also conserved among these regions. Consistent with our observations at promoters, enhancers also demonstrate a catalytic-independent requirement of Integrator in RNAPII recruitment. However, it was proposed that RNAPII pausing at enhancers is more transient compared to promoters, as evidenced by a lower RNAPII TR and increased susceptibility to P-TEFb inhibition ([@R17]). In support, the enhancer TM revealed that Integrator has a limited contribution to RNAPII pause-release at these regulatory elements. At promoters of human genes, the enzymatic activity of INTS11 is needed to promote elongation through the dynamic turnover of paused RNAPII, while at enhancers, the catalytic activity of INTS11 is strictly utilized for eRNA termination and plays little role in promoting pause-release and elongation. Collectively, these data indicate that Integrator catalyzes the termination of transcripts during distinct stages of transcription at human enhancers and promoters.

ChIP-seq studies examining occupancy of the pause factors NELF-E and SPT5 corroborate the role of Integrator in mediating recruitment of RNAPII and facilitating pause-release at promoters. Moreover, the increased recruitment of pause factors was unique to promoters and was not seen at enhancers. The reduced occupancy of RNAPII-S5 at class III genes substantiates the role of Integrator in RNAPII recruitment, while its unchanged levels at class IV genes signifies that the accumulation of PRO-seq signal at promoters was due to impaired pause-release and not increased initiation. Importantly, the elevation in RNAPII-Y1 occupancy at paused genes and enhancers highlight the requirement for Integrator in the termination of transcripts at these sites. At promoter-proximal sites, Integrator induces the premature termination of nascent transcripts, while at enhancers, Integrator processes the 3′ end of eRNAs.

Recent studies have elegantly shown that RNAPII undergoes dynamic cycles of initiation, pausing, premature termination, and eviction prior to the establishment of a RNAPII complex that transitions to productive elongation ([@R14]; [@R21]; [@R47]). Our data indicate that Integrator is central to this model, as we demonstrate its catalytic-independent recruitment of RNAPII and catalytic-dependent premature termination of nascent transcripts associated with paused RNAPII. We propose that at human genes, Integrator is key for mediating dynamic turnover of RNAPII through these dual functions, thus balancing the cycle of initiation and early termination events to promote productive elongation of RNAPII.
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### Lead Contact {#S14}

Further information and requests for resources and reagents should be directed to and will be fulfilled by Ramin Shiekhattar: <rshiekhattar@med.miami.edu>.

### Materials Availability {#S15}

The reagents generated in this study will be readily shared via materials transfer agreement.

### Data and Code Availability {#S16}

All sequencing data generated in this study is made available at the Gene Expression Omnibus (GEO). The accession number for the raw and processed data reported in this paper is GEO: GSE125534, GSE125535

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S17}
--------------------------------------

Cell lines were maintained in mycoplasma-free conditions and were routinely tested for infection. HeLa INTS11 and GFP inducible knockdown clones were established as previously described ([@R23]). HeLa rescue cells were established by cloning the same shINTS11 sequence into Tet-pLKO-neo vector (Addgene) and single clones were selected with G418 (500 μg/ml). shRNA-resistant N-terminal Flag-tagged WT or E203Q mutant INTS11 cDNA ([@R2]) were cloned into Cumate-pLenti-Cloning-2A-GFP vector (ABM Inc.), and transfected into a shINTS11-Tet-pLKO-neo single clone. Stable cell lines were maintained in puromycin (2 μg/ml) and G418 (200 μg/ml) containing DMEM medium.

METHOD DETAILS {#S18}
--------------

### RNA isolation {#S19}

Total RNA was extracted using Trizol reagent (Thermo Fisher Scientific, \#15596026) according to the manufacturer's instructions. Genomic DNA was removed by Turbo DNase treatment (Invitrogen, \#AM1907).

### Library preparation {#S20}

ChIP-seq libraries were generated using the NEBNext Ultra II DNA library prep kit (New England Biolabs, \#E7645S) with at least 10 ng of input DNA. Total RNA-seq libraries were produced using Truseq Stranded Total RNA library prep kit (Illumina, \#20020596) with 500 ng of DNase-treated Input RNA. Small RNA libraries were prepared using the SMARTer smRNA-seq kit (Takara, \#635030) with 750 ng of Nuclear-enriched total RNA. Genome-wide experiments were performed as two independent biological replicates. To avoid a batch effect in library preparation and sequencing flow cell, these replicates were processed together.

### PRO-seq and data analysis {#S21}

PRO-seq experiments were performed as described previously ([@R28]). Nuclei were isolated by Dounce homogenizer with loose pestle. 1×10\^7 nuclei were subjected to nuclear run-on (30°C, 3 min) in the presence of 25 μM Biotin-11-ATP/GTP/CTP/UTP (PerkinElmer). Total RNA was extracted and hydrolyzed in 0.2 M NaOH (on ice, 10 min). Biotinylated nascent RNAs were purified by Dynabeads M-280 streptavidin (Invitrogen). Following adaptor ligation, cDNA synthesis, and PCR amplification 140--350 bp libraries were size-selected by Pippin HT with 2% gel cassette 20B (Sage Science) then sequenced by NextSeq 500 system (Illumina) with single-read runs. Raw fastq data were trimmed by Cutadapt 1.14 ([@R29]) and Trimmomatic v0.32 ([@R4]), and then aligned on hg19 or dm3 genome by bowtie 1.1.2 ([@R24]). Strand-specific single nucleotide ends of aligned reads were generated by BEDTools v2.28 with genomecov ([@R38]) as bedgraph format. Bedgraph data were normalized by the number of reads mapped to spike-in dm3 genome, and then converted to bigwig data, which were used for downstream analyses.

### CAGE library preparation and analysis {#S22}

CAGE library preparation, sequencing and mapping were performed by DNAFORM (Kanagawa, Japan), the CAGE library prep is based on nAnTiCAGE protocol ([@R31]). Briefly first strand cDNAs were transcribed to the 5′ end of capped RNAs and were attached to CAGE "bar code„ tags. Multiplex deep sequencing of two cDNA libraries (shGFP without dox) was performed on an Illumina HiSeq2500 sequencer. The sequenced CAGE tags were mapped to the human genome hg19 using BWA ([@R26]) and used the a filter of MAPQ \> = 20. Next, we removed the rRNA from the bam files. The reads with MAPQ \< 20 in BWA were mapped again by HISAT2 ([@R19]) we keep only the unique mapped reads (with the tag NH:i:1) and sum with the BWA mapped reads these were utilized in subsequent analyses. For tag clustering, the CAGE-tag were input for RECLU clustering, with a maximum irreproducible discovery rate (IDR) of 0.1 ([@R34]). We used BedTools command closest to annotated the CAGE peaks against ENSENBL (v87). Peaks with distance \> 500nt from an annotated TSS region were discarded to avoid multiple CAGE signals assigned to the same promoter. When multiple peaks were detected in the same promoter, we considered the CAGE peak with lower IDR. The gene isoforms related with the annotated TSS by CAGE was considered for further analysis if we detect a FPKM \> 0 in total RNA-seq of INTS11 shRNA with or without dox. We used deepTool2 ([@R40]) to generate normalized bigwig.

### ChIP-Seq and data analysis {#S23}

ChIP-seq was performed as previously described ([@R15]; [@R23]; [@R55]) with slight modifications. 2 × 10^7^ cells were crossl-inked in 1% formaldehyde for 10 minutes at room temperature and quenched with 125 mM glycine. For INTS11 ChIP, samples were crosslinked with Cross-link Gold (Diagenode C01019027) according to the manufacturer's instructions prior to formaldehyde fixation. Samples were resuspended in ChIP lysis buffer (20 mM Tris-HCl, 50 mM NaCl, 0.1% SDS, 0.5% Triton X-100, 1 mM EDTA) and sonicated in a Covaris M220 focused sonicator until chromatin fragments of 150-300 bp were produced. Protein A/G magnetic beads were bound with antibody and incubated with 1 mg of sonicated chromatin overnight. The following day, beads were washed twice with Mixed Micelle Buffer (150 mM NaCl, 1% Triton X-100, 0.2% SDS, 20 mM Tris-HCl, 5 mM EDTA, 65% sucrose), Buffer 500 (500 mM NaCl, 1% Triton X-100, 0.1% Na deoxycholate, 25 mM HEPES, 10 mM Tris-HCl, 1 mM EDTA), LiCl/detergent wash (250 mM LiCl, 0.5% Na deoxycholate, 0.5% NP-40, 10 mM Tris-HCl, 1 mM EDTA), and eluted in Decrosslinking Buffer (20 mM Tris-HCl, 300 mM NaCl, 0.5% SDS, 1 mM EDTA) at 65°C. Eluates were treated with RNase A for 1 hour at 37°C and then Proteinase K for 3 hours at 56°C. The DNA was finally purified by phenol/chloroform and eluted in 1x TE. Raw FASTQ data were processed with Trimmomatic v0.32 to remove low-quality reads and then aligned to the human genome hg19 using STAR aligner v2.5.3a ([@R9]). We used deepTool2 ([@R40]) to generate normalized bigwig and heatmaps. Peaks were called using MACS2.1.2 ([@R57]) with default parameters --shiftsize 75 --nomodel--extsize 200 --p 0.01 for all data. Whole-cell extract input from the corresponding cell lines were used as controls. Peaks with fold change \> 3 and a q-value \< 0.01 were used for downstream analysis. Homer annotatePeaks v4.9.1-5 ([@R16]) was used for peak annotation and intergenic peaks were selected for eRNA identification.

### ATAC-seq and data analysis {#S24}

ATAC-seq experiments were performed as previously described ([@R7]), with the following modification. DNA libraries were quantified using Qubit dsDNA high sensitivity reagents (Thermo Fisher Scientific) and measured Qubit 2 fluorometer. The samples were pooled and sequenced, paired-end, 75bp on a NextSeq 500. ATAC-seq analysis was performed as described in [@R5] for nucleosome position we used the common peaks shINTS11 without dox as input for NucleoATAC ([@R43]).

### RNA-seq data analysis {#S25}

Raw fastq RNA-seq data were processed with Trimmomatic v0.32 ([@R4]) and aligned to human genome (hg19 version) using STAR aligner v2.5.3a ([@R9]) with default parameters and RSEM v1.2.31 ([@R25]) to obtain expected gene counts against the human Ensembl (release 87). To select genes for downstream analysis, we extended the TSS positions (defined by the CAGE peaks) by 500 base pair toward to the3′end. We overlapped the nucleosome position defined by NucleoATAC ([@R43]) and used the closet nucleosome to the CAGE peak to capture the +1 nucleosome dyad center position. The genes with no nucleosome in the 500nt window were excluded from the subsequent analysis. We merged the 2 PRO-Seq biological replicates for each condition, shINTS11 with and without dox, and excluded all TSS region with a CPM \< 0.5 in both conditions. The remaining TSS were defined as all genes (n = 8000). Differential expression was determined between INTS11 shRNA +Dox or INTS9 shRNA +Dox or INTS4 shRNA +Dox against GFP shRNA +Dox or INTS11 shRNA (+Dox versus −Dox) and GFP shRNA (+Dox versus −Dox) using DESeq2 ([@R27]) and R v3.2.3 with *q*-value \< 0.05. For visualization on the UCSC Genome Browser, all tracks were CPM (count per million) normalized against the total number of usable reads in that dataset using deep Tools2 ([@R40]). Gene Ontology analysis was performed using DAVID (v6.8) online tool with standard parameters (<https://david.ncifcrf.gov/home.jsp>).

### Small RNA analysis {#S26}

Reads were then adaptor trimmed (AAAAAAA) as recommend by SMARTer smRNA-seq kit (Takara, \#635030) protocol using Cutadapt (v1.14) and reads less than 17 bp were discarded. First, we aligned the reads against human elements in RepBase (v23.08) with STAR (v2.5.3a), repeat-mapping reads were removed all others were then mapped against the full human genome (hg19 version) keeping all uniquely aligned reads. For visualization on the UCSC Genome Browser, all tracks were CPM (count per million) normalized against the total number of usable reads in that dataset using deepTools2 ([@R40]). The average smRNA length profiles were calculated with the first quartile of all gene classes and we used a window from CAGE peak to +150 nt for the calculation.

### Differentially paused genes modeling {#S27}

PRO-seq was used to calculate the traveling ratio (TR) as previously described in [@R39]. Briefly, we calculated the ratio between the RPKM values in promoter region (−50 nt from CAGE to + 300 nt) over the region corresponding to the gene body (+301 nt from CAGE to TES) for all transcripts used in the analysis (n = 8000). The traveling matrix (TM) can be visualized as a 2D distribution by using the log~2~ ratio (RPKM ~−*Dox*~/ RPKM ~+*Dox*~) of promoter region (x axis) and gene body (y axis). To access the genes with differential pause after INTS11 depletion, we developed a pause relative metric using a 2D Gaussian distribution model. First, we calculated a null model dispersion based in the Control shRNA (−Dox) and (+Dox) observed changes. The two-dimensional Control shRNA relative distribution was estimated using a 2D Gaussian probabilistic model, with the number of mixture k= 1 using the numerical Expectation Maximization (EM) algorithm with a convergence threshold \< 1e-3. To select the genes from INTS11 shRNA condition presenting a significant relative pause value (FDR \< 0.01), we exclude those genes that show a high probability to belong to the null Control shRNA. The relative difference generated by this 2D representation can be categorized in four different groups:

Class 1: log~2~ promoter \> 0 and log~2~ gene body \< 0

Class 2: log~2~ promoter \< 0 and log~2~ gene body \< 0

Class 3: log~2~ promoter \> 0 and log~2~ gene body \> 0

Class 4: log~2~ promoter \< 0 and log~2~ gene body \> 0

The model can be summarized as:

p = Log~2~(−Dox/+Dox) RPKM at the −50 nt CAGE peak up to + 300 nt window region.

c = Log~2~(−Dox/+Dox) RPKM from the CAGE peak +301 nt up to gene TES.

p = {*p*~1~, *p*~2~ ... *p~n~*}, where, P is populated with the *p* shControl values.

C = {*c*~1~, *c*~2~ ... *c~n~*}, where, C is populated with the *c* shControl values.

μ, Σ = EM (P, C), where the parameters from the multivariate Gaussian distribution μ (mean vector) and Σ (2x2 covariance matrix) are estimated using the Expectation Maximization algorithm.

**x** = \[***p***~***shINTs*11**~,***c***~***shINTS*11**~\], is a vector containing the values *p* and *c* for a given gene in the shINTS11 condition

We defined the probability of a gene *x be* differentially paused by using the following 2D multivariate normal joint probability distribution equation: $$p(\mathbf{x} \mid \mu,\Sigma) = 1 - \left( {\frac{1}{\sqrt{(2\pi)^{2} \mid \Sigma \mid}}\left( {- \frac{1}{2}(\mathbf{x} - \mu)^{T}\Sigma^{- 1}(\mathbf{x} - \mu)} \right)} \right)$$

After obtaining the differential pause probability for the genes in the INTS11 shRNA condition, we selected as significant those genes that presented an adjusted probability FDR \< 0.01. The 2D Gaussian model and prediction was estimated using the python sklearn mixture package version 0.21.1 ([@R36]).

### Genome-wide identification of eRNA loci {#S28}

For eRNA identification, we first defined a set of intergenic enhancers by using the BEDTools Window (v2.28.0) function to overlap H3K27ac and H3K4me1 intergenic peaks (defined in [ChIP-Seq and data analysis](#S23){ref-type="sec"} section) in a window of ± 200 bp. After identifying intergenic regions containing H3K27ac/H3K4me1 peaks, the BEDtools Intersect function was used with the option --v to discard any peaks that overlap with any gene from the hg19 reference genome (ENSENBL v87), including an additional 2 kb upstream of every TSS. In order to determine which intergenic enhancers presented transcriptional activity, we separated the mapped read from PRO-seq by strand and individually call peaks using MACS2.1.2 ([@R57]) with the following parameters --nomodel--extsize 200--broad-cutoff 0.1 and −broad to identify broad peaks. We merge the common peaks from each samples (Control shRNA and INTS11 shRNA) for each stranded peaks and later all the peaks from common plus strand were merge with common minus strand peaks. BEDtools intersect between the intergenic enhancer peaks and the common peaks from PRO-Seq was use to define the enhancer that contain eRNAs. We excluded all transcripts with less than 800nt, in order to minimize any bias in the TR analysis, since these eRNAs are short to precisely separate promoter and gene body regions. Lastly, we define the TSS coordinate for each eRNA based on the position of the highest signal occurrence in the PRO-Seq peak window and discarded those with CPM \> 0.5. For eRNA TR calculation we use as promoter region (−100 nt from PRO-seq summit to + 150 nt) and gene body (+151 nt from PRO-seq summit to TES plus 1kb) all transcripts used in the analysis (n = 2293). The output from the TR calculation was used as input for the traveling matrix pipeline described above.

### Microscopy STORM imaging {#S29}

Cells (4x10^3^) were plated onto micro slide 4 well plates (Ibidi), fixed in 4% formaldehyde, and immunostained with appropriate primary and secondary antibodies. Imaging experiments were carried out with a Nikon eclipse Ti2 microscope equipped with Nikon Instruments (NSTORM). For two color imaging dSTORM imaging, Janelia Fluor 646 \[Novus Bio NBP1-7-2739JF646 Lot \#36481-051615\] was used as a secondary staining for INTS1 and Alexa Fluor 568 \[Invitrogen A11077 Lot \#1917936\] was used as a secondary staining for RPB1 Tyr-1. The secondary antibodies were used with MEA STORM imaging buffer and were imaged continuously with 5000 frames collected per filter range at a frequency of 30 ms. The images were acquired using a 100x, 1.49 NA objective, and imaged onto a Hamamatsu C11440 ORCA-flash 4.0. Storm analysis was carried out with Nikon Elements Analysis 5.02.01 for identification of molecules. Molecule list files were then exported from Nikon elements to be further analyzed using software Clus-Doc software in MATLAB R2018b ([@R35]). Cluster density analysis, specifically DBSCAN function, was carried out after manually selecting region of interest corresponding to the nucleus. Statistical significance and graphing were performed using Prism software.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S30}
---------------------------------------

Significance was determined by either Student's t test, non-parametric Wilcox test or Kolmogorov--Smirnov test, as indicated. Error bars in figures represent standard deviation (SD) of at least two independent experiments.
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![Integrator Regulates Steady-State Gene Expression\
(A--C) Volcano plot depicting differentially expressed genes after (A) INTS11 shRNA, (B) INTS9 shRNA, and (C) INTS4 shRNA determined by RNA-seq (n = 24,832 genes, fold change = 1.5, q-value \> 0.05).\
(D and E) Venn diagram of common (D) downregulated genes and (E) upregulated genes among cells depleted of INTS11, INTS9, or INTS4.](nihms-1613941-f0002){#F1}

![Integrator Mediates Transcriptional Elongation\
(A) Spearman correlation of RNAPII and INTS11 ChIP-seq occupancy centered on the TSS (CAGE peak ±200 bp) of 8,000 genes.\
(B) Hypothetical schematic of control condition "A" whereby treatments producing conditions "B" and "C" generate identical traveling ratio (TR) values by distinct transcriptional mechanisms.\
(C and D) TM of control shRNA cells (C) and INTS11 shRNA cells (D).\
(E) Differential TM of INTS11 shRNA cells.\
(F and G) ChIP-seq promoter profiles of INTS11 (F) and RNAPII (G) centered on the +1 nucleosome dyad at gene classes defined by the differential TM. Kolmogorov-Smirnov (KS) test p value \< 0.001 for classes paired against class IV.\
(H and I) PRO-seq examples of class IV genes *SEL1L* (H) and *MED4* (I) in control shRNA cells and INTS11 shRNA cells without and with shRNA induction.](nihms-1613941-f0003){#F2}

![Integrator Relieves RNAPII Pausing Adjacent to the +1 Nucleosome Dyad\
(A and B) PRO-seq promoter-proximal read density and gene body profile at class I and II genes in control shRNA cells (A) and INTS11 shRNA cells (B) without and with shRNA induction. KS test p value = 0.01 of class I promoter and gene body profiles (−Dox versus +Dox). KS test p value \<0.001 of class II promoter and gene body profiles (−Dox versus +Dox).\
(C and D) PRO-seq promoter-proximal read density and gene body profile at class III and IV genes in control shRNA cells (C) and INTS11 shRNA cells (D) without and with shRNA induction. KS test p value \< 0.001 for class III and IV (−Dox versus +Dox) promoter and gene body profiles.\
(E) RNAPII ChIP-seq promoter and gene body profiles at class I and II genes without and with INTS11 shRNA induction. KS test p value \< 0.05 and 0.01 for class I and II (−Dox versus +Dox) promoter profiles, respectively, and KS test p value \< 0.05 for gene body profiles.\
(F) RNAPII ChIP-seq promoter and gene body profiles at class III and IV genes without and with INTS11 shRNA induction. KS test p value \< 0.0001 and 0.05 for class III and IV (−Dox versus +Dox) promoter profiles, respectively, and KS test p value \< 0.001 for gene body profiles.\
(G and H) Mononucleosome profile at class I and II genes in control shRNA cells (G) and INTS11 shRNA cells (H) without and with shRNA induction.\
(I and J) Mononucleosome profile at class III and IV genes in control shRNA cells (I) and INTS11 shRNA cells (J) without and with shRNA induction.](nihms-1613941-f0004){#F3}

![INTS11 Catalysis Facilitates RNAPII Elongation\
(A and B) PRO-seq promoter-proximal read density and gene body profile at class I and II genes in INTS11 shRNA cells expressing WT-INTS11 (A) and INTS11 shRNA cells expressing E203Q-INTS11 (B) without and with shRNA induction. KS test p value \< 0.0001 for class II (−Dox versus +Dox) promoter profile and KS test p value \< 0.05 and 0.01 for class I and II (−Dox versus +Dox) gene body profiles, respectively.\
(C and D) PRO-seq promoter-proximal read density and gene body profile at class III and IV genes in INTS11 shRNA cells expressing WT-INTS11 (C) and INTS11 shRNA cells expressing E203Q-INTS11 (D) without and with shRNA induction. KS test p value \< 0.0001 for class IV (−Dox versus +Dox) promoter profile and KS test p value \< 0.001 for class III and IV (−Dox versus +Dox) gene body profiles. PRO-seq promoter profiles are centered on the +1 nucleosome dyad. PRO-seq examples of class IV genes.\
(E and F) *SEL1L* (E) and *MED4* (F) in INTS11 shRNA cells expressing WT-INTS11 and INTS11 shRNA cells expressing E203Q-INTS11 without and with shRNA induction.](nihms-1613941-f0005){#F4}

![INTS11 Catalyzes the Termination of Small RNA Associated with Paused RNAPII\
(A) smRNA whole gene profile of all expressed genes (n = 8000) in INTS11 shRNA cells.\
(B and C) Boxplot of log~2~(+Dox/−Dox) smRNA counts per million (CPM) at (B) Class IV and (C) Class III genes, t test; \*\*\*p value \< 0.001.\
(D) Boxplot of smRNA read length at all genes in INTS11 shRNA cells expressing WT-INTS11 and INTS11 shRNA cells expressing E203Q-INTS11. t test; \*\*\*p value \< 0.001.\
(E and F) smRNA mean size distribution centered on the TSSs of class IV (E) and class III (F) genes in control shRNA cells and INTS11 shRNA cells without and with shRNA induction.\
(G and H) smRNA mean size distribution centered on the TSSs of class IV (G) and class III (H) genes in INTS11 shRNA cells expressing WT-INTS11 and INTS11 shRNA cells expressing E203Q-INTS11 without and with shRNA induction.\
(I--L) smRNA read length distribution at all genes in control shRNA cells (I), INTS11 shRNA cells (J), INTS11 shRNA cells expressing WT-INTS11 (K), and INTS11 shRNA cells expressing E203Q-INTS11 (L) without and with shRNA induction.\
(M and N) smRNA examples of class IV genes *SEL1L* (M) and *MED4* (N) in control shRNA cells, INTS11 shRNA cells, INTS11 shRNA cells expressing WT-INTS11, and INTS11 shRNA cells expressing E203Q-INTS11 without and with shRNA induction.](nihms-1613941-f0006){#F5}

![Enhancer RNA Transcriptional Termination Requires INTS11 Catalysis\
(A--D) PRO-seq enhancer profile (n = 2,293) in control shRNA cells (A), INTS11 shRNA cells (B), INTS11 shRNA cells expressing WT-INTS11 (C), and INTS11 shRNA cells expressing E203Q-INTS11 (D) without and with shRNA induction.\
(E--H) PRO-seq enhancer TSS profile in control shRNA cells (E), INTS11 shRNA cells (F), INTS11 shRNA cells expressing WT-INTS11 (G), and INTS11 shRNA cells expressing E203Q-INTS11 (H) without and with shRNA induction. KS test p value \< 0.001 for all conditions (−Dox versus +Dox).\
(I and J) Enhancer TM of control shRNA cells (I) and INTS11 shRNA cells (J).\
(K) Differential enhancer TM of INTS11 shRNA cells.](nihms-1613941-f0007){#F6}

![Pausing Factors and Tyrosine-1-Phosphorylated RNAPII Convey Integrator Functions\
(A) NELF-E ChIP-seq promoter profile at class III and -IV genes without and with shRNA induction in INTS11 shRNA cells. KS test p value \< 0.0001 for class III and IV (−Dox versus +Dox), respectively.\
(B) SPT5 ChIP-seq promoter profile at class III and IV genes without and with shRNA induction in INTS11 shRNA cells. KS test p value \< 0.0001 for class III and IV (−Dox versus +Dox), respectively.\
(C) NELF-E ChIP-seq enhancer profile without and with shRNA induction in INTS11 shRNA cells.\
(D) SPT5 ChIP-seq enhancer profile without and with shRNA induction in INTS11 shRNA cells.\
(E) RNAPII-Y1 ChIP-seq promoter profile at class III and IV genes without and with shRNA induction in INTS11 shRNA cells. KS test p value \< 0.0001 for class III and IV (−Dox versus +Dox), respectively.\
(F) RNAPII-Y1 ChIP-seq enhancer profile without and with shRNA induction in INTS11 shRNA cells.\
(G) STORM images of INTS1, RNAPII-Y1, and a merge without and with shRNA induction in INTS11 shRNA cells.\
(H) Quantification of RNAPII-Y1 cluster density without and with shRNA induction in INTS11 shRNA cells (n = 8, \*\*p \< 0.01).\
(I) Model depicting Integrator mediating premature termination of nascent transcripts and subsequent recruitment of elongation-competent RNAPII complex.](nihms-1613941-f0008){#F7}

###### 

KEY RESOURCES TABLE

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  REAGENT or RESOURCE                             SOURCE                                                                IDENTIFIER
  ----------------------------------------------- --------------------------------------------------------------------- -------------------------------------
  Antibodies                                                                                                            

  Rabbit polyclonal Anti-INTS11 (ChIP and\        Atlas Antibodies                                                      Cat\# HPA029025; RRID: AB_10600425
  western)                                                                                                              

  Rabbit polyclonal Anti-INTS11 (ChIP)            Abcam                                                                 Cat\# 75276; RRID: AB_1280958

  Rabbit polyclonal Anti-INTS9                    Atlas Antibodies                                                      Cat\# HPA051615; RRID: AB_2681552

  Rabbit polyclonal Anti-INTS4                    Bethyl Laboratories                                                   Cat\# A301-296A; RRID: AB_937909

  Mouse monoclonal Anti-INTS1                     Millipore                                                             Cat\# MABS1984; RRID: AB_2848204

  Mouse monoclonal Anti-Lamin A                   Active Motif                                                          Cat\# 39962; RRID: AB_2615028

  Rabbit monoclonal Anti-GAPDH                    Cell Signaling Technology                                             Cat\# 5174; RRID: AB_10622025

  Rabbit monoclonal Anti-RPB1 NTD                 Cell Signaling Technology                                             Cat\# 14958; RRID: AB_2687876

  Rabbit polyclonal Anti-RNA pol II CTD\          Abcam                                                                 Cat\# ab5095; RRID: AB_304749
  phospho S2 - RPB1 Ser-2                                                                                               

  Rabbit polyclonal Anti-RNA pol II CTD\          Abcam                                                                 Cat\# ab5131; RRID: AB_449369
  phospho S5 - RPB1 Ser-5                                                                                               

  Rat monoclonal Anti-RNA Pol II CTD\             Active Motif                                                          Cat\# 61383; RRID: AB_2793613
  phospho Tyr1 - RPB1 Tyr-1                                                                                             

  Rabbit polyclonal Anti-NELF-E                   Santa Cruz Biotechnology                                              Cat\# sc-377052; NA

  Rat monoclonal Anti-SPT5                        Millipore                                                             Cat\# MABE1803; RRID: AB_2848205

  Rabbit polyclonal Anti-Histone H3K4me1          Abcam                                                                 Cat\# ab8895; RRID: AB_306847

  Rabbit polyclonal Anti-Histone H3K4me3          Diagenode                                                             Cat\# pAb-003-050; RRID: AB_2616052

  Rabbit polyclonal Anti-Histone H3K36me3         Abcam                                                                 Cat\# ab9050; RRID: AB_306966

  Rabbit polyclonal Anti-Histone H3K27ac          Diagenode                                                             Cat\# C15410196; RRID: AB_2637079

  Goat anti-Rat IgG Secondary Antibody,\          Thermo Fisher Scientific                                              Cat\# A11077; RRID: AB_2534121
  Alexa Fluor 568                                                                                                       

  Goat anti-Mouse IgG Secondary Antibody,\        Novus Biologicals                                                     Cat\# NBP1-72739JF646; RRID:\
  Janelia Fluor 646                                                                                                     AB_2857337

  Chemicals, Peptides, and Recombinant Proteins                                                                         

  Turbo DNase                                     Invitrogen                                                            cat\# AM1907

  Biotin-11-NTPs                                  Perkin Elmer                                                          Cat\# NEL54(2/3/4/5)001

  Dynabeads M-280 streptavidin                    Invitrogen                                                            Cat\# 11205

  Cross-link Gold                                 Diagenode                                                             Cat\# C01019027

  Critical Commercial Assays                                                                                            

  NEBNext Ultra II DNA library prep kit           NEB                                                                   Cat\# E7645S

  Truseq Stranded Total RNA library prep kit      Illumina                                                              Cat\# 20020596

  SMARTer smRNA-seq kit                           Takara                                                                Cat\# 635030

  Nextera DNA Library Prep Kit                    Illumina                                                              Cat\# FC-121-1030

  Deposited Data                                                                                                        

  Raw and analyzed data                           This paper                                                            GEO: GSE125534

  Raw and analyzed data                           This paper                                                            GEO: GSE125535

  Experimental Models: Cell Lines                                                                                       

  HeLa shGFP                                      [@R15]                                                                N/A

  HeLa shINTS11                                   [@R15]                                                                N/A

  HeLa shINTS11 - FLAG - E203Q - INTS11           This paper                                                            N/A

  HeLa shINTS11 - FLAG - WT-INTS11                This paper                                                            N/A

  Recombinant DNA                                                                                                       

  Tet-pLKO-puro vector                            addgene                                                               Cat\# 21915

  Tet-pLKO-neo vector                             addgene                                                               Cat\# 21916

  Cumate-pLenti-Cloning-2A-GFP vector             ABM inc.                                                              Cat\# iCu003

  Software and Algorithms                                                                                               

  Cutadapt v1.14                                  [@R29]                                                                N/A

  Trimmomatic v0.32                               [@R4]                                                                 N/A

  Bowtie v1.1.2                                   [@R24]                                                                N/A

  BEDTools v2.28                                  [@R38]                                                                N/A

  STAR v2.5.3a                                    [@R9]                                                                 N/A

  deepTools2                                      [@R40]                                                                N/A

  MACS2 v2.1.2                                    [@R57]                                                                N/A

  Homer annotatePeaks v4.9.1-5                    [@R16]                                                                N/A

  ATAC-seq pipeline                               <https://github.com/kundajelab/atac_dnase_pipelines>                  N/A

  NucleoATAC                                      [@R43]                                                                N/A

  RSEM v1.2.31                                    [@R25]                                                                N/A

  DESeq2                                          [@R27]                                                                N/A

  RECLU clustering                                [@R34]                                                                N/A

  Prism v7.0c                                     GraphPad                                                              N/A

  Clus-Doc MATLAB R2018b                          [@R35]                                                                N/A

  MATLAB R2018b                                   <https://www.mathworks.com/products/new_products/release2018b.html>   N/A

  Nikon Elements Analysis 5.02.01                 Nikon                                                                 N/A
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

###### Highlights

-   Integrator promotes transcription elongation at human genes

-   The RNA endonuclease of Integrator subunit 11 is critical for gene activation

-   Integrator functions at human genes decorated with H3K4me3 and H3K36me3
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